Vital Farms (VITL) opened 2026 with Q1 revenue of US$187.2 million and a basic EPS loss of US$0.03, compared with net income of US$16.9 million and basic EPS of US$0.38 in Q1 2025. Over that period, revenue moved from US$162.2 million to US$187.2 million while EPS shifted from a profit of US$0.38 to a small loss. This set up a quarter where top line growth met pressure on the bottom line. For you as an investor, the headline is a set of results where sales continue to build but margins and earnings power face a tougher test.

See our full analysis for Vital Farms.

With the latest numbers on the table, the next step is to see how they line up with the key Vital Farms narratives that investors have been leaning on over the past year, and where those stories might need updating.

Margins Swing From Profit To Loss

• Across the last five reported quarters, Vital Farms moved from Q1 2025 net income of US$16.9 million and basic EPS of US$0.38 to a Q1 2026 net loss of US$1.5 million and basic EPS of US$0.03 loss, even though quarterly revenue in those same Q1 periods went from US$162.2 million to US$187.2 million.
• Bulls point out that trailing 12 month revenue of US$784.4 million and net income of US$47.9 million sit alongside a trailing net margin of 6.1%, and argue that capacity expansion and brand strength can support future earnings. However, the move from an 8.3% margin a year earlier and the swing into a Q1 loss keep pressure on the bullish case.
  • Consensus bullish assumptions rely on revenue growing around 17.7% per year with profit margins moving from 8.7% to 3.9%. This means the current 6.1% trailing margin and the loss in the latest quarter sit below those earlier margin levels used in bullish narratives.
  • At the same time, trailing basic EPS of US$1.07 on a 12 month basis is still positive, so bulls may focus on the full year profile rather than the single quarter loss when they compare it with their expectation that earnings reach US$48.1 million by 2029.

Bulls argue that the recent dip in margin and the Q1 loss are growing pains tied to capacity and promotion investments rather than a reset in Vital Farms' long term profitability story, and that is what the optimistic narrative tries to unpack in more detail. 🐂 Vital Farms Bull Case

Valuation Signals Versus Slower Earnings

• Vital Farms trades on a trailing P/E of 8.5x at a share price of US$9.52, compared with a peer average of 52.2x and a US Food industry average of 17x, while trailing 12 month EPS is US$1.07 and net income is US$47.9 million.
• Bears highlight that trailing net margin has shifted from 8.3% to 6.1% and that earnings are forecast to grow 5.93% per year, slower than the cited 16.4% for the broader US market, and argue that this helps explain why the stock trades on a lower P/E even if headline valuation metrics look compressed.
  • Bearish narratives assume revenue growth of about 20.5% per year with margins edging from 8.7% to 7.3%, which is still above the current 6.1% trailing margin, so the present margin level sits closer to the cautious side of those expectations.
  • The same bearish view expects earnings of about US$97.2 million by 2029, whereas the most recent trailing 12 month net income figure of US$47.9 million shows the company around halfway to that level, giving bears room to argue that any slowdown in margin recovery could weigh on that path.

Skeptics suggest that the combination of a lower P/E multiple and easing margins fits more with the cautious narrative than with a simple mispricing story, and that is exactly the tension the more cautious analysis digs into. 🐻 Vital Farms Bear Case

DCF Gap And Earnings Quality Flag

• The reported DCF fair value of US$160.82 per share sits far above the current share price of US$9.52, and this appears alongside a high level of non cash earnings and a trailing net profit margin of 6.1% versus 8.3% a year earlier.
• What stands out for both bullish and bearish narratives is that this very large gap to DCF fair value is paired with a risk flag around non cash earnings, so investors weighing either side need to consider that trailing 12 month net income of US$47.9 million may not fully match cash generation.
  • Rewards data point to forecast revenue growth of about 14% per year and a trailing P/E of 8.5x, which some investors view as supportive of value appeal when set against the high DCF fair value figure.
  • Risks data, however, highlight that a material portion of earnings is non cash and that margins have moved from 8.3% to 6.1%, which can lead more cautious investors to focus on how closely cash flow tracks reported profit before leaning too heavily on modelled fair values.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Vital Farms on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With bulls and bears both finding support in the same set of numbers, now is a good time to review the figures yourself and see which story makes more sense to you, especially with 3 key rewards and 1 important warning sign

See What Else Is Out There

Vital Farms is dealing with a shift from Q1 profit to loss, softer margins and a large DCF gap that raises questions around earnings quality.

If those margin pressures and earnings quality concerns give you pause, it may be helpful to compare them with companies screened for 72 resilient stocks with low risk scores so you can evaluate businesses that currently score better on risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.